Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Vivian A. Gray"'
Autor:
Vivian A. Gray
Publikováno v:
Analytical Testing for the Pharmaceutical GMP Laboratory. :206-250
Publikováno v:
Dissolution Technologies. 29:104-108
Publikováno v:
Dissolution Technologies. 27:6-19
Publikováno v:
Dissolution Technologies. 27:40-42
Autor:
Vivian A. Gray
Publikováno v:
In Vitro Drug Release Testing of Special Dosage Forms. :253-284
Autor:
Kent L. Amsberry, Daniel W. Armstrong, S. Baertschi, James Bergum, Ping Chen, A.M. Clarke, Ian Clegg, Jennifer E. Dally, Vivian A. Gray, Brian L. He, Qin C. Ji, E. Kikovska-Stojanovska, Ryan Klein, Yin Hwa Lai, David K. Lloyd, Myrna A. Monck, Kurt L. Moyer, B. Olsen, John D. Orr, Li Pan, Ernest Parente, R.L. Phelps, George L. Reid, Christopher M. Riley, Thomas W. Rosanske, Michael Ruberto, James R. Scull, Eric B. Sheinin, Pamela A. Smith, Mohsen Talebi, Kailas Thakker, Patrick A. Tishmack, Linna Wang, Qinggang Wang, Harry Yang, Long Yuan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::472892fa33b35609e7d07fad1966bfdb
https://doi.org/10.1016/b978-0-08-102824-7.01002-2
https://doi.org/10.1016/b978-0-08-102824-7.01002-2
Autor:
Vivian A. Gray
Publikováno v:
AAPS PharmSciTech
For a dissolution method to be considered relevant to in vivo performance, the dissolution data profiles should show discrimination or meaningful change when there is a change in critical material attributes (CMAs) and critical product properties (CP
Autor:
Okponanabofa Eradiri, Susan Cady, Johannes Krämer, David Curran, James DeMuth, Erika S. Stippler, John Shabushnig, Vivian A. Gray, Munir A. Hussain
Publikováno v:
Dissolution Technologies. 25:8-13